Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Aakaar Medical Technologies Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Aakaar Medical Technologies Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Aakaar Medical Tech - Price movement
-
Aakaar Medical Tech - Updates
-
Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Aakaar Medical Tech - Price movement
-
Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Aakaar Medical Tech - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Aakaar Medical Tech has submitted to BSE the Shareholding Pattern for the Period Ended June 26, 2025
-
Aakaar Medical Technologies Ltd. debuts with 4.16% premium at Rs 75.00
-
Aakaar Medical Tech announces launch of initial public offering
Key fundamentals
Evaluate the intrinsic value of Aakaar Medical Technologies Ltd stock
Name | March-25 | March-24 | |||
---|---|---|---|---|---|
Assets | 45.9411 | 27.5982 | |||
Liabilities | 45.9411 | 27.5982 | |||
Equity | 10.4224 | 0.7 | |||
Gross Profit | 9.7369 | 4.9989 | |||
Net Profit | 6.0395 | 2.8702 | |||
Cash From Operating Activities | -5.4063 | -8.0441 | |||
NPM(%) | 9.8 | 6.22 | |||
Revenue | 61.5828 | 46.111 | |||
Expenses | 51.8459 | 41.1121 | |||
ROE(%) | 22.4 | 10.64 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Aakaar Medical Technologies Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 878.25 | -1.44 | 29.14 | 0.00 | 301.39 | 0.57 |
Lotus Eye Hospital and Institute Ltd | 72.49 | -1.28 | 207.11 | 0.00 | 3.55 | 0.00 |
Vaishali Pharma Ltd | 12.70 | 2.92 | 211.67 | 0.00 | 3.13 | 0.00 |
Astec Lifesciences Ltd | 879.50 | -2.96 | 0.00 | 0.00 | -601.21 | 0.00 |
Company Info
Our Company was originally incorporated as `Aakaar Medical Technologies Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our shareholders at an extraordinary general meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of our Company from `Aakaar Medical Technologies Private Limited' to `Aakaar Medical Technologies Limited'.Major Events:2013- Incorporated as Aakaar Medical Technologies Private Limited.2016- Entered into licensing, marketing and distribution agreement with Medytox Inc., South Korea for launch of Siax.2017- Launched our own brands Tubelite.- Launched our own brand Balback.- Launched our own brand Lytec.2018-Entered into a tripartite agreement with ACPL and Croma Pharma GmbH for launch of Saypha filler (earlier known as Princess).2022- Launched our own brand Etrelume.2023- Launched our own brand Swyada.- Entered into exclusive agreement in licensing, marketing and distribution with Regenera Activa Worldwide S.L for launch of Regenera ActivaAMT.- Entered into exclusive agreement in licensing, marketing and distribution with Tesslift Co. Limited.2024- Launched our own brand Exoluxe and DRS1512.- Launched our Own brand Eoluxe.- Conversion of our Company from a private limited company to a public limited company.
Our Company was originally incorporated as `Aakaar Medical Technologies Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our shareholders at an extraordinary general meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of our Company from `Aakaar Medical Technologies Private Limited' to `Aakaar Medical Technologies Limited'.Major Events:2013- Incorporated as Aakaar Medical Technologies Private Limited.2016- Entered into licensing, marketing and distribution agreement with Medytox Inc., South Korea for launch of Siax.2017- Launched our own brands Tubelite.- Launched our own brand Balback.- Launched our own brand Lytec.2018-Entered into a tripartite agreement with ACPL and Croma Pharma GmbH for launch of Saypha filler (earlier known as Princess).2022- Launched our own brand Etrelume.2023- Launched our own brand Swyada.- Entered into exclusive agreement in licensing, marketing and distribution with Regenera Activa Worldwide S.L for launch of Regenera ActivaAMT.- Entered into exclusive agreement in licensing, marketing and distribution with Tesslift Co. Limited.2024- Launched our own brand Exoluxe and DRS1512.- Launched our Own brand Eoluxe.- Conversion of our Company from a private limited company to a public limited company.
Read More
Parent Organisation
Aakaar Medical Technologies Ltd.
Founded
20/06/2013
Managing Director
Mr.Rahul Babasaheb Sawakhande
NSE Symbol
AAKAARSM
FAQ
The current price of Aakaar Medical Technologies Ltd is
The 52-week high for Aakaar Medical Technologies Ltd is
The market capitalization of Aakaar Medical Technologies Ltd is currently
This value can fluctuate based on stock price movements and changes in the number of shares outstanding.To buy Aakaar Medical Technologies Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Aakaar Medical Technologies Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aakaar Medical Technologies Ltd shares.
The CEO of Aakaar Medical Technologies Ltd is Mr.Rahul Babasaheb Sawakhande, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.